SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
AstraZeneca
AstraZeneca
Page 8 of 13
Health
The COVID-19 vaccination drive may be slow—but it’s already faster than any in history
By
Jeremy Kahn
January 17, 2021
Health
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
By
Lars Erik Taraldsen
,
Naomi Kresge
and
Bloomberg
January 15, 2021
Health
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
By
James Paton
and
Bloomberg
January 13, 2021
Health
EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
By
Naomi Kresge
and
Bloomberg
January 6, 2021
Health
U.K. approves AstraZeneca COVID-19 vaccine
By
Jeremy Kahn
December 30, 2020
Health
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By
Viren Vaghela
,
Thomas Penny
and
Bloomberg
December 28, 2020
Newsletters
Why Wall Street is ‘signaling caution’ for your stock portfolio in 2021
By
Bernhard Warner
December 15, 2020
Finance
Why shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal
By
Jeremy Kahn
December 14, 2020
Newsletters
COVID vaccines are coming—but it might be too late for the housing market
By
Bernhard Warner
December 14, 2020
Health
AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
By
John Lauerman
,
James Paton
and
Bloomberg
December 13, 2020
Health
Who gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence
By
Katherine Dunn
December 8, 2020
Newsletters
The global rally stalls out, but Goldman Sachs is doubling down on value stocks
By
Bernhard Warner
December 7, 2020
Health
Airlines are facing ‘mission of the century’ in shipping COVID vaccines
By
Christopher Jasper
,
William Wilkes
and
Bloomberg
December 1, 2020
International
AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India
By
Naomi Xu Elegant
November 30, 2020
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By
Suzi Ring
,
James Paton
and
Bloomberg
November 27, 2020
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
By
Jessica Coacci
Economy
Mortgage rates plunge to 11-month low on Fed rate cut hopes, and many lenders may quote in the high 5% range
By
Jason Ma